|
1
|
Zhuge H, Ge Z, Wang J, Yao J, He J, Wang Y, Wang Y, Tang Y. The Tandem of Liquid Chromatography and Network Pharmacology for the Chemical Profiling of Pule'an Tablets and the Prediction of Mechanism of Action in Treating Prostatitis. Pharmaceuticals (Basel) 2023; 17:56. [PMID: 38256890 PMCID: PMC10821205 DOI: 10.3390/ph17010056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Revised: 12/25/2023] [Accepted: 12/25/2023] [Indexed: 01/24/2024] Open
Abstract
Prostatitis, a prevalent urinary tract disorder in males, has a complex etiology that leads to severe clinical discomfort. Pule'an Tablets, a classic single-component formulation primarily based on rapeseed pollen, have been clinically proven to have a beneficial therapeutic effect on both prostatitis and benign prostatic hyperplasia. However, there is currently a lack of research on the chemical composition and mechanisms of action of Pule'an Tablets in treating prostatitis. In this study, using liquid chromatography-mass spectrometry (LC-MS), a total of 53 compounds in Pule'an Tablets were identified, including flavonoids, phenylpropionamides, lipids, glucosinolates, and nucleic acids. Subsequently, through a network pharmacology analysis, potential target genes and their mechanisms of action were predicted accordingly. The results suggested that genes such as LPAR5, LPAR6, LPAR4, LPAR3, LPAR2, LPAR1, F2, ENPP2, MMP9, and TNF, along with pathways like prostate cancer, endocrine resistance, bladder cancer, and the IL-17 signaling pathway, may represent potential pathways involved in the therapeutic effects of Pule'an Tablets. This study represents the first systematic investigation into the chemical composition of Pule'an Tablets, shedding light on the potential mechanisms underlying their efficacy in treating prostatitis. These findings could serve as a valuable reference for future pharmacological research on Pule'an Tablets.
Collapse
Affiliation(s)
- Hui Zhuge
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; (H.Z.); (Y.W.)
- Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310018, China
| | - Zhiwei Ge
- Analysis Center of Agrobiology and Environment Sciences & Institute of Agrobiology and Environment Sciences, Zhejiang University, Hangzhou 310058, China; (Z.G.); (J.W.)
| | - Jiaojiao Wang
- Analysis Center of Agrobiology and Environment Sciences & Institute of Agrobiology and Environment Sciences, Zhejiang University, Hangzhou 310058, China; (Z.G.); (J.W.)
| | - Jianbiao Yao
- Zhejiang CONBA Pharmaceutical Co., Ltd., Hangzhou 310052, China; (J.Y.); (J.H.)
- Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Pharmaceutical Technology, Hangzhou 310052, China
| | - Jiayu He
- Zhejiang CONBA Pharmaceutical Co., Ltd., Hangzhou 310052, China; (J.Y.); (J.H.)
- Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Pharmaceutical Technology, Hangzhou 310052, China
| | - Yi Wang
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; (H.Z.); (Y.W.)
| | - Yingchao Wang
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; (H.Z.); (Y.W.)
- Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310018, China
| | - Yu Tang
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; (H.Z.); (Y.W.)
- Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310018, China
| |
Collapse
|